Johns Hopkins University
Clinical trials sponsored by Johns Hopkins University, explained in plain language.
-
Peer buddies may keep liver transplant patients off alcohol
Disease control Not yet recruitingThis study tests whether peer support specialists—people who have been through liver transplant for alcohol-related disease themselves—can help others in the same situation stay sober and attend medical appointments. About 95 participants will meet regularly with a peer supporter…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
HIV-Positive livers for HIV-Positive patients: a new hope?
Disease control Not yet recruitingThis study looks at whether people with HIV who need a liver transplant can safely receive a liver from a donor who also had HIV. Researchers will compare infections and cancer rates between those who get an HIV-positive donor liver and those who get an HIV-negative donor liver. …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New team approach aims to simplify care for heart and kidney health
Disease control Not yet recruitingThis study tests a 6-month program where patients work with a pharmacist and their primary care doctor to make shared decisions about medications and lifestyle. The goal is to see if this team-based approach improves heart and kidney health scores and medication adherence. The st…
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Brain pacemaker trial aims to quiet voices in Treatment-Resistant schizophrenia
Disease control Not yet recruitingThis pilot study will test whether deep brain stimulation (DBS) can help people with schizophrenia who still hear voices and have delusions despite trying multiple medications. Fifteen adults will have electrodes placed in a brain region linked to schizophrenia symptoms. The goal…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common mineral slow Alzheimer's? new trial begins
Disease control Not yet recruitingThis early-stage trial tests whether lithium orotate, a form of the mineral lithium, is safe and reaches the brain in people with early Alzheimer's. Forty adults with confirmed Alzheimer's will take either the supplement or a placebo for 9 weeks. Researchers will measure lithium …
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Old drug, new hope? emetine trial targets dengue deaths
Disease control Not yet recruitingThis study tests whether the drug emetine can help people hospitalized with dengue fever. About 600 adults aged 18 to 65 will take either a low or high dose of emetine or a placebo pill for 7 days. Researchers will track if the drug reduces deaths or stops the disease from becomi…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a diabetes drug and an addiction pill curb alcohol cravings?
Disease control Not yet recruitingThis Phase 2 trial at Johns Hopkins will test whether combining semaglutide (a GLP-1 drug used for diabetes) with naltrexone (a medication for alcohol dependence) is safe and helps reduce alcohol use. About 45 adults with alcohol use disorder will take the combination or a placeb…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a simple sugar ease Crohn's? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial tests whether an oral supplement called N-acetylglucosamine (GlcNAc) can safely help control Crohn's disease in the ileum or ileocolon. Forty adults with stable Crohn's will receive either GlcNAc or a placebo for 6 weeks, then switch after a washout period. The…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a salt substitute safely lower blood pressure? new study investigates
Disease control Not yet recruitingThis study will test whether a low-sodium salt substitute, which contains potassium chloride, is safe for adults with high blood pressure who are on medication. About 607 participants in Bangladesh will replace regular salt with the substitute for a period. Researchers will monit…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a sleep medication curb alcohol cravings?
Disease control Not yet recruitingThis study tests whether daridorexant, a drug used for insomnia, can reduce alcohol cravings and drinking while improving sleep in people with alcohol use disorder and sleep problems. About 150 adults will receive either daridorexant or a placebo for several weeks. The goal is to…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Hair salons join the fight against high blood pressure in women of color
Disease control Not yet recruitingThis pilot study will test whether training hair stylists to check blood pressure, combined with home monitoring, health coaching, and pharmacist support, can help Black and Hispanic women lower their blood pressure. About 144 women who visit participating salons will be randomly…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
AI stethoscope aims to cut unnecessary antibiotics in kids with cough
Diagnosis Not yet recruitingThis study tests whether an AI-powered digital stethoscope can help health workers more accurately diagnose pneumonia in children aged 2 months to 5 years. 350 children with cough or breathing difficulty will be randomly assigned to standard care or care plus the AI stethoscope. …
Phase: PHASE4 • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New Finger-Stick test could diagnose hepatitis c in the ER in just one hour
Diagnosis Not yet recruitingThis study looks at whether a new finger-stick test for hepatitis C, which gives results in about an hour, is acceptable to patients in the emergency department. Researchers will enroll 200 adults who have tested positive for hepatitis C antibodies but don't know if they have an …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
A simple chat or text could stop diabetes before it starts
Prevention Not yet recruitingThis pilot study tests whether a single, personalized conversation with a healthcare team member or a brief message through a patient portal can encourage adults with prediabetes to take action—like joining a diabetes prevention program or starting medication. Researchers will co…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Nepal trial tests community program to prevent lung disease
Prevention Not yet recruitingThis study tests whether a program led by community health workers can improve lung health for 800 people in Bhaktapur, Nepal, who are at risk for chronic respiratory diseases. The program includes tobacco cessation counseling, mask use during high pollution, handwashing, and flu…
Phase: PHASE4 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Robot meditation may beat apps for better sleep in seniors
Symptom relief Not yet recruitingThis study tests whether a handheld robot that guides meditation with touch and voice can improve sleep quality in older adults with mild memory concerns. 100 participants will either use the robot or a standard meditation app for daily sessions. The goal is to see if the robot h…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Simple bedroom tweaks may boost sleep for seniors with memory issues
Symptom relief Not yet recruitingThis pilot study tests whether simple bedroom changes and sleep tips can improve sleep for older adults (65+) who live alone, have memory concerns, and struggle with insomnia. Over 8 weeks, researchers will visit participants' homes to adjust the bedroom environment and provide s…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Zapping pain away: new device could help kids with cancer ditch pain pills
Symptom relief Not yet recruitingThis study tests a device called Scrambler Therapy to relieve nerve pain in children with cancer that has spread to the bone. The treatment is non-invasive and aims to lower pain levels and reduce the need for pain medications. About 70 children who can describe their pain will t…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Zapping the brain to heal after injury: new study tests tDCS for TBI
Symptom relief Not yet recruitingThis study tests whether a safe, noninvasive brain stimulation technique called tDCS, combined with thinking exercises, can improve attention, memory, and problem-solving in people who had a traumatic brain injury at least two years ago. About 20 adults will receive personalized …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
AI-Powered brain zaps aim to sharpen fading memories
Symptom relief Not yet recruitingThis study tests a personalized, non-invasive brain stimulation device for 10 people with mild cognitive impairment (MCI). The device uses AI to tailor electrical stimulation to each person's brain patterns while they do memory exercises. The goal is to see if this approach can i…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
AI-powered brain zaps aim to slow language loss in dementia
Symptom relief Not yet recruitingThis study tests a personalized brain stimulation device for people with primary progressive aphasia (PPA), a condition that slowly destroys language abilities. Ten participants will receive daily 30-minute sessions over three weeks, where an AI analyzes their brain activity and …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could CBD ease alcohol withdrawal? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether cannabidiol (CBD), a compound from cannabis, can reduce alcohol withdrawal symptoms and cravings in people with moderate-to-severe alcohol use disorder. 105 adults will stay in a hospital for 5 days, receive either CBD or a placebo alongside standard care…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Quick trip? LSD plus risperidone tested for depression
Symptom relief Not yet recruitingThis early-phase study tests whether a shortened LSD experience, combined with the drug risperidone, can safely ease symptoms of major depression. Ten adults with moderate to severe depression will receive LSD followed by risperidone 45 minutes later. Researchers will monitor saf…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Could a heart ointment help heal leg wounds after surgery?
Symptom relief Not yet recruitingThis early study tests whether applying nitroglycerin ointment (a medicine that widens blood vessels) to surgical wounds during high-risk leg surgeries can improve blood flow and reduce complications like infection or wound separation. Fifteen adults undergoing specific ankle, he…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can a breathing gadget calm anxious teens?
Symptom relief Not yet recruitingThis study tests whether a biofeedback breathing system called Freespira can reduce anxiety and panic symptoms in young people aged 9 to 17. Over 8 weeks, one group uses the device while a control group waits. The goal is to see if the device helps lower anxiety scores on a stand…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a common supplement ease severe behaviors in rare genetic disorder?
Symptom relief Not yet recruitingThis pilot study tests whether N-acetylcysteine (NAC), an antioxidant supplement, can reduce repetitive and self-injurious behaviors in people with Cornelia de Lange syndrome (CdLS). Ten participants aged 13–35 will receive both NAC and a placebo in random order over 18 weeks. Th…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Sleep study targets racism stress impact on insomnia treatment
Symptom relief Not yet recruitingThis study looks at whether racism-related stress affects how well a digital cognitive behavioral therapy program (Sleepio) works for insomnia in Black adults. One hundred participants will use the app for 6-10 weeks while researchers track their sleep and stress levels. The goal…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Pedal to preserve sight: study tests if exercise slows glaucoma damage
Symptom relief Not yet recruitingThis study looks at whether a 12-week home exercise program (cycling and resistance training) can improve vision and quality of life in people with glaucoma. Researchers will measure changes in visual field sensitivity, eye blood flow, and oxygen use. The goal is to see if exerci…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Bedtime ketone drink tested as new sleep apnea aid
Symptom relief Not yet recruitingThis study tests whether drinking a ketone supplement (Ketone-IQ) before sleep can improve sleep quality and reduce breathing pauses in people with moderate-to-severe obstructive sleep apnea. Thirty adults who already use CPAP will try the ketone drink for two nights and a placeb…
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can a simple questionnaire help parents of preemies with lung disease?
Symptom relief Not yet recruitingThis pilot study tests whether a pre-visit questionnaire helps Black parents of preterm infants with chronic lung disease set and achieve health goals during primary care visits. Thirty parents will complete the questionnaire before a well-child visit and then report back on goal…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 26, 2026 18:38 UTC
-
Your smartwatch could predict blood sugar crashes before they happen
Knowledge-focused Not yet recruitingThis study will test whether combining continuous glucose monitor (CGM) data with information from a smartwatch and a phone app (like meals and activity) can better predict blood sugar levels in people with type 2 diabetes. Thirty-six adults will wear a CGM and smartwatch and log…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Magic mushroom study seeks to unlock Brain's mood secrets
Knowledge-focused Not yet recruitingThis study will give 20 healthy adults a single dose of psilocybin (the active ingredient in magic mushrooms) to see how it changes mood and well-being. Some participants will also get a drug called pimavanserin beforehand to help understand which brain receptors are involved. Th…
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
AI-Powered video review could revolutionize surgeon training
Knowledge-focused Not yet recruitingThis pilot study tests a new software platform called SOAR that uses AI to analyze videos of surgeries and give feedback to surgical trainees. About 100 participants, including residents and attending surgeons at Johns Hopkins, will use the app to review their own operations and …
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Can your eyes reveal if You're too high to drive?
Knowledge-focused Not yet recruitingThis study looks at how different doses of THC (the active ingredient in cannabis) affect eye movements and attention. Researchers will test 40 adults—some who use cannabis often and some who use it rarely—to see if eye-tracking can reliably detect impairment. The goal is to deve…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Hemp lotion absorption under the microscope: new study launches
Knowledge-focused Not yet recruitingThis early-stage study will test how a hemp-based CBD lotion with a small amount of THC is absorbed by the body. Twenty healthy adults will use the lotion in a clean, controlled environment. Researchers will measure cannabinoid levels in saliva, blood, and urine over time to unde…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Cannabis study to reveal if indica vs. sativa really matters
Knowledge-focused Not yet recruitingThis study will test 70 healthy adults aged 21-55 to see how cannabis products labeled as indica, sativa, or generic affect thinking, driving, and feelings. Participants will complete memory tasks, driving simulations, and questionnaires after using cannabis. The goal is to under…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New PET tracer aims to spot brain inflammation in ALS
Knowledge-focused Not yet recruitingThis early-phase study tests a special dye called [11C]CPPC used in PET scans to see if it can safely detect brain inflammation in people with ALS. Researchers will compare scans from 20 ALS patients and healthy volunteers to check if the dye highlights areas of inflammation and …
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Hospital-Made 3D splints could save time and money in jaw surgery
Knowledge-focused Not yet recruitingThis study will compare custom 3D printed splints made at the hospital with those made by outside companies for jaw surgery. The splints help surgeons align the teeth and jaws correctly during the operation. Researchers want to see if the in-house splints are faster to get, cheap…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Healthy eyes get glaucoma drops to uncover injury secrets
Knowledge-focused Not yet recruitingThis study looks at how the optic nerve changes when eye pressure is lowered in people who do not have glaucoma. About 30 adults over age 30 will have their optic nerve photographed before and after using a daily glaucoma eye drop for two weeks. The goal is to compare these resul…
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Scientists test THC and Beta-Myrcene vapor in small human study
Knowledge-focused Not yet recruitingThis early-stage study will give 32 healthy adults who use cannabis vaporized THC, beta-myrcene, or a placebo to see how these substances affect their feelings of being high and sleepy. Researchers want to learn how beta-myrcene, a compound found in cannabis and other plants, cha…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can a 50-Minute chat help new moms on opioid meds and their families?
Knowledge-focused Not yet recruitingThis study looks at whether a 50-minute education session can help pregnant and new mothers taking medication for opioid use disorder, along with a friend or family member, learn more about their treatment and newborn withdrawal. Researchers will measure how many women are intere…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC